KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2023 | $2,592 | -81.6% | 245 | -78.7% | 0.00% | -100.0% |
| Q1 2023 | $14,065 | +160.6% | 1,150 | +164.4% | 0.00% | +100.0% |
| Q4 2022 | $5,398 | -40.0% | 435 | -34.5% | 0.00% | -50.0% |
| Q3 2022 | $9,000 | -35.7% | 664 | -10.3% | 0.00% | 0.0% |
| Q2 2022 | $14,000 | +7.7% | 740 | -7.4% | 0.00% | 0.0% |
| Q1 2022 | $13,000 | -50.0% | 799 | -57.5% | 0.00% | -50.0% |
| Q4 2021 | $26,000 | +1200.0% | 1,878 | +1655.1% | 0.00% | +300.0% |
| Q3 2021 | $2,000 | 0.0% | 107 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 107 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $3,000 | 0.0% | 107 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $3,000 | 0.0% | 107 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,000 | +50.0% | 107 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | +100.0% | 107 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |